A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders

Paula Scholz, Lebriz Altay, Sascha Fauser, Paula Scholz, Lebriz Altay, Sascha Fauser

Abstract

Micropulse laser treatment is an alternative to the conventional continuous-wave laser for the treatment of retinal or macular diseases. In contrast to the conventional laser, the therapeutic effect of the subthreshold micropulse laser is not accompanied by thermal retinal damage. This fact is of particular importance when a treatment near the fovea is required. Micropulse treatment is applied in indications such as central serous chorioretinopathy (CSC), diabetic macular edema (DME), or macular edema due to retinal vein occlusion (RVO). This review outlines and discusses the published literature of subthreshold micropulse laser treatment for CSC, DME, and macular edema after RVO.

Keywords: Central serous chorioretinopathy; Diabetic macular edema; Micropulse laser; Ophthalmology; Retinal vein occlusion; Subthreshold laser.

References

    1. Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol. 1985;103:1796–1806. doi: 10.1001/archopht.1985.01050120030015.
    1. Robertson DM, Ilstrup D. Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol. 1983;95(4):457–466. doi: 10.1016/0002-9394(83)90265-9.
    1. Ficker L, Vafidis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol. 1988;72(11):829–834. doi: 10.1136/bjo.72.11.829.
    1. The Branch Vein Occlusion Study Group Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98(3):271–282. doi: 10.1016/0002-9394(84)90316-7.
    1. The Diabetic Retinopathy Study Research Group Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81(4):383–396. doi: 10.1016/0002-9394(76)90292-0.
    1. Ulbig MR, Arden GB, Hamilton AP. Color contrast sensitivity and pattern electroretinographic findings after diode and argon laser photocoagulation in diabetic retinopathy. Am J Ophthalmol. 1994;117(5):583–588. doi: 10.1016/S0002-9394(14)70063-7.
    1. Lewen RM. Subretinal neovascularization complicating laser photocoagulation of diabetic maculopathy. Ophthal Surg Lasers Imaging Retina. 1988;19(10):734–737.
    1. Smith CW, Guyer DR, D’Amico DJ. Subretinal fibrosis after laser photocoagulation for diabetic macular edema. Am J Ophthalmol. 1992;113(6):652–656. doi: 10.1016/S0002-9394(14)74789-0.
    1. Seiberth V, Alexandridis E, Feng W. Function of the diabetic retina after panretinal argon laser coagulation. Graefes Arch Clin Exp Ophthalmol. 1987;225(6):385–390. doi: 10.1007/BF02334163.
    1. Pearson A, Tanner V, Keightley S, Casswell A. What effect does laser photocoagulation have on driving visual fields in diabetics? Eye (Lond) 1998;12(1):64–68. doi: 10.1038/eye.1998.12.
    1. Roider J. Laser treatment of retinal diseases by subthreshold laser effects. Semin Ophthalmol. 2009;14(19–26).
    1. Bresnick GH. Diabetic maculopathy: a critical review highlighting diffuse macular edema. Ophthalmology. 1983;90(11):1301–1317. doi: 10.1016/S0161-6420(83)34388-8.
    1. Wilson AS, Hobbs BG, Shen W-Y, et al. Argon laser photocoagulation-induced modification of gene expression in the retina. Invest Ophthalmol Vis Sci. 2003;44(4):1426–1434. doi: 10.1167/iovs.02-0622.
    1. Dorin G. Evolution of retinal laser therapy: minimum intensity photocoagulation (MIP). Can the laser heal the retina without harming it? Semin Ophthalmol. 2004;19(1–2):62–8.
    1. Inagaki K, Shuo T, Katakura K, Ebihara N, Murakami A, Ohkoshi K. Sublethal photothermal stimulation with a micropulse laser induces heat shock protein expression in ARPE-19 cells. J Ophthalmol. 2015;2015:729792.
    1. Lanzetta P, Dorin G, Pirracchio A, Bandello F. Theoretical bases of non-ophthalmoscopically visible endpoint photocoagulation. Semin Ophthalmol. 2001;16(1):8–11.
    1. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524–527. doi: 10.1126/science.6836297.
    1. Roider J, Hillenkamp F, Flotte T, Birngruber R. Microphotocoagulation: selective effects of repetitive short laser pulses. Proc Natl Acad Sci. 1993;90(18):8643–8647. doi: 10.1073/pnas.90.18.8643.
    1. Roider J, Michaud NA, Flotte TJ, Birngruber R. Response of the retinal pigment epithelium to selective photocoagulation. Arch Ophthalmol. 1992;110(12):1786–1792. doi: 10.1001/archopht.1992.01080240126045.
    1. Dorin G, editor. Subthreshold and micropulse diode laser photocoagulation. Seminars in Ophthalmology. 2003;18(3):147–53.
    1. McHugh J, Marshall J, Ffytche T, Hamilton A, Raven A. Macular photocagulation of human retina with a diode laser: a comparative histopathological study. Lasers Light Ophthalmol. 1990;3(1):11–28.
    1. Vogel A, Birngruber R. Temperature profiles in human retina and choroid during laser coagulation with different wavelengths ranging from 514 to 810 nm. Lasers Light Ophthalmol. 1992;5(1):9–16.
    1. Peyman GA, Raichand M, Zeimer RC. Ocular effects of various laser wavelengths. Surv Ophthalmol. 1984;28(5):391–404. doi: 10.1016/0039-6257(84)90244-3.
    1. Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology. 1997;104(12):2030–2038. doi: 10.1016/S0161-6420(97)30061-X.
    1. Friberg TR, Venkatesh MdS. Alteration of pulse configuration affects the pain response during diode laser photocoagulation. Lasers Surg Med. 1995;16(4):380–383. doi: 10.1002/lsm.1900160409.
    1. Mainster MA. Wavelength selection in macular photocoagulation: tissue optics, thermal effects, and laser systems. Ophthalmology. 1986;93(7):952–958. doi: 10.1016/S0161-6420(86)33637-6.
    1. Ricci F, Missiroli F, Cerulli L. Indocyanine green dye-enhanced micropulsed diode laser: a novel approach to subthreshold RPE treatment in a case of central serous chorioretinopathy. Eur J Ophthalmol. 2004;14(1):74–82.
    1. Ricci F, Missiroli F, Regine F, Grossi M, Dorin G. Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2009;247(5):597–607. doi: 10.1007/s00417-008-1014-1.
    1. Chen S-N, Hwang J-F, Tseng L-F, Lin C-J. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology. 2008;115(12):2229–2234. doi: 10.1016/j.ophtha.2008.08.026.
    1. Lanzetta P, Furlan F, Morgante L, Veritti D, Bandello F. Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur J Ophthalmol. 2007;18(6):934–940.
    1. Gupta B, Elagouz M, McHugh D, Chong V, Sivaprasad S. Micropulse diode laser photocoagulation for central serous chorio-retinopathy. Clin Exp Ophthalmol. 2009;37(8):801–805. doi: 10.1111/j.1442-9071.2009.02157.x.
    1. Koss M, Beger I, Koch F. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye (Lond) 2011;26(2):307–314. doi: 10.1038/eye.2011.282.
    1. Roisman L, Magalhães FP, Lavinsky D, et al. Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial. Ophthalmic Surg Lasers Imaging Retina. 2013;44(5):465–470. doi: 10.3928/23258160-20130909-08.
    1. Malik KJ, Sampat KM, Mansouri A, Steiner JN, Glaser BM. Low-intensity/high-density subthreshold micropulse diode laser for chronic central serous chorioretinopathy. Retina. 2015;35(3):532–536. doi: 10.1097/IAE.0000000000000285.
    1. Kretz FT, Beger I, Koch F, Nowomiejska K, Auffarth GU, Koss MJ. Randomized clinical trial to compare micropulse photocoagulation versus half-dose verteporfin photodynamic therapy in the treatment of central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina. 2015;46(8):837–843. doi: 10.3928/23258160-20150909-08.
    1. Elhamid AHA. Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy. Clin Ophthalmol. 2015;9:2277.
    1. Scholz P, Ersoy L, Boon CJ, Fauser S. Subthreshold micropulse laser (577 nm) treatment in chronic central serous chorioretinopathy. Ophthalmologica. 2015;234(4):189–194. doi: 10.1159/000439600.
    1. Kim JY, Park HS, Kim SY. Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2015;253(12):2129–35.
    1. Gawęcki M. Increase in central retinal edema after subthreshold diode micropulse laser treatment of chronic central serous chorioretinopathy. Case Rep Ophthalmol Med. 2015;2015:813414.
    1. Yadav N, Jayadev C, Mohan A, et al. Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome. Eye (Lond). 2015;29(2):258–64.
    1. Breukink MB, Mohr JK, Ossewaarde-van Norel A, et al. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol. Acta Ophthalmol. 2016;94(2):187–197. doi: 10.1111/aos.12938.
    1. Özmert E, Demirel S, Yanık Ö, Batıoğlu F. Low-fluence photodynamic therapy versus subthreshold micropulse yellow wavelength laser in the treatment of chronic central serous chorioretinopathy. J Ophthalmol. 2016;2016:3513794.
    1. Ambiya V, Goud A, Mathai A, Rani PK, Chhablani J. Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy. Clin Ophthalmol. 2016;10:1513. doi: 10.2147/OPTH.S112431.
    1. Scholz P, Altay L, Fauser S. Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy. Eye (Lond). 2016;30(10):1371–7.
    1. Fazel F, Bagheri M, Golabchi K, Ardakani HJ. Comparison of subthreshold diode laser micropulse therapy versus conventional photocoagulation laser therapy as primary treatment of diabetic macular edema. J Curr Ophthalmol. 2016;28(4):206–211. doi: 10.1016/j.joco.2016.08.007.
    1. Inagaki K, Ohkoshi K, Ohde S, Deshpande GA, Ebihara N, Murakami A. Comparative efficacy of pure yellow (577-nm) and 810-nm subthreshold micropulse laser photocoagulation combined with yellow (561–577-nm) direct photocoagulation for diabetic macular edema. Jpn J Ophthalmol. 2015;59(1):21–28. doi: 10.1007/s10384-014-0361-1.
    1. Vujosevic S, Martini F, Longhin E, Convento E, Cavarzeran F, Midena E. Subthreshold micropulse yellow laser versus subthreshold micropulse infrared laser in center-involving diabetic macular edema: morphologic and functional safety. Retina. 2015;35(8):1594–1603. doi: 10.1097/IAE.0000000000000521.
    1. Othman IS, Eissa SA, Kotb MS, Sadek SH. Subthreshold diode-laser micropulse photocoagulation as a primary and secondary line of treatment in management of diabetic macular edema. Clin Ophthalmol. 2014;8:653.
    1. Venkatesh P, Ramanjulu R, Azad R, Vohra R, Garg S. Subthreshold micropulse diode laser and double frequency neodymium:YAG laser in treatment of diabetic macular edema: a prospective, randomized study using multifocal electroretinography. Photomed Laser Surg. 2011;29(11):727–733. doi: 10.1089/pho.2010.2830.
    1. Lavinsky D, Cardillo JA, Melo LA, Dare A, Farah ME, Belfort R. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Invest Ophthalmol Vis Sci. 2011;52(7):4314–4323. doi: 10.1167/iovs.10-6828.
    1. Ohkoshi K, Yamaguchi T. Subthreshold micropulse diode laser photocoagulation for diabetic macular edema in Japanese patients. Am J Ophthalmol. 2010;149(1):133–139. doi: 10.1016/j.ajo.2009.08.010.
    1. Nakamura Y, Mitamura Y, Ogata K, Arai M, Takatsuna Y, Yamamoto S. Functional and morphological changes of macula after subthreshold micropulse diode laser photocoagulation for diabetic macular oedema. Eye (Lond) 2010;24(5):784–788. doi: 10.1038/eye.2009.207.
    1. Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina. 2010;30(6):908–916. doi: 10.1097/IAE.0b013e3181c96986.
    1. Figueira J, Khan J, Nunes S, et al. Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol. 2009;93(10):1341–1344. doi: 10.1136/bjo.2008.146712.
    1. Laursen M, Moeller F, Sander B, Sjoelie A. Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br J Ophthalmol. 2004;88(9):1173–1179. doi: 10.1136/bjo.2003.040949.
    1. Parodi MB, Iacono P, Bandello F. Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment. Graefes Arch Clin Exp Ophthalmol. 2015;253(10):1647–1651. doi: 10.1007/s00417-014-2845-6.
    1. Inagaki K, Ohkoshi K, Ohde S, Deshpande GA, Ebihara N, Murakami A. Subthreshold micropulse photocoagulation for persistent macular edema secondary to branch retinal vein occlusion including best-corrected visual acuity greater than 20/40. J Ophthalmol. 2014;2014:251257.
    1. Parodi MB, Iacono P, Ravalico G. Intravitreal triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: a pilot study. Br J Ophthalmol. 2008;92(8):1046–1050. doi: 10.1136/bjo.2007.128025.
    1. Parodi MB, Spasse S, Iacono P, Di Stefano G, Canziani T, Ravalico G. Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology. 2006;113(12):2237–2242. doi: 10.1016/j.ophtha.2006.05.056.
    1. Gregori NZ, Feuer W, Rosenfeld PJ. Novel method for analyzing snellen visual acuity measurements. Retina. 2010;30(7):1046–1050. doi: 10.1097/IAE.0b013e3181d87e04.
    1. Gass J. Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol. 1967;63:587–615.
    1. Gilbert CM, Owens SL, Smith PD, Fine SL. Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol. 1984;68(11):815–820. doi: 10.1136/bjo.68.11.815.
    1. Fok AC, Chan PP, Lam DS, Lai TY. Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy. Ophthalmic Res. 2011;46(3):160–163. doi: 10.1159/000324599.
    1. Wang MS, Sander B, Larsen M. Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol. 2002;133(6):787–793. doi: 10.1016/S0002-9394(02)01438-1.
    1. Schatz H, Yannuzzi LA, Gitter KA. Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis? Retina. 2012;32:OP-893–OP-906. doi: 10.1097/IAE.0b013e318242fa2d.
    1. Schatz H, Madeira D, McDonald HR, Johnson RN. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol. 1991;109(11):1549–1551. doi: 10.1001/archopht.1991.01080110085041.
    1. Khosla P, Rana S, Tewari H, Azad R, Talwar D. Evaluation of visual function following argon laser photocoagulation in central serous retinopathy. Ophthalmic Surg Lasers. 1997;28(8):693–697.
    1. Piccolino FC, Eandi CM, Ventre L, de la Longrais RCR, Grignolo FM. Photodynamic therapy for chronic central serous chorioretinopathy. Retina. 2003;23(6):752–763. doi: 10.1097/00006982-200312000-00002.
    1. Chan W, Lam D, Lai T, Tam B, Liu D, Chan C. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol. 2003;87(12):1453–1458. doi: 10.1136/bjo.87.12.1453.
    1. Colucciello M. Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. Retina. 2006;26(2):239–242. doi: 10.1097/00006982-200602000-00027.
    1. Lai TY, Chan W-M, Lam DS. Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol. 2004;137(5):826–833. doi: 10.1016/j.ajo.2003.11.079.
    1. Bandello F, Lanzetta P, Furlan F, Polito A. Non visible subthreshold micropulse diode laser treatment of idiopathic central serous chorioretinopathy. A pilot study. Investig Ophtalmol Vis Sci. 2003;44(5):4858.
    1. Early Treatment Diabetic Retinopathy Study Research Group Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology. 1991;98(5):766–785. doi: 10.1016/S0161-6420(13)38011-7.
    1. Morgan CM, Schatz H. Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation. Ophthalmology. 1989;96(1):96–103. doi: 10.1016/S0161-6420(89)32924-1.
    1. Greer D, Constable I, Cooper R. Macular oedema and retinal branch vein occlusion. Aust J Opthalmol. 1980;8(3):207–209. doi: 10.1111/j.1442-9071.1980.tb00340.x.
    1. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801. doi: 10.1016/j.ophtha.2011.12.039.
    1. Chen G, Tzekov R, Li W, Jiang F, Mao S, Tong Y. Subthreshold micropulse diode laser versus conventional laser photocoagulation for diabetic macular edema: a meta-analysis of randomized controlled trials. Retina. 2016;36(11):2059–2065. doi: 10.1097/IAE.0000000000001053.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner